Ocular Therapeutix, Inc. (OCUL)
Total Valuation
OCUL has a market cap or net worth of $445.97 million. The enterprise value is $369.14 million.
| Market Cap | 445.97M |
| Enterprise Value | 369.14M |
Important Dates
The latest earnings date was Monday, August 8, 2022, after market close.
| Last Earnings Date | Aug 8, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 76.76 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Shares Outstanding | 76.76M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 58.45% |
| Float | 70.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.93 |
| Forward PS | 4.78 |
| PB Ratio | 6.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.14, with a Debt / Equity ratio of 0.90.
| Current Ratio | 6.14 |
| Quick Ratio | 6.00 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -40.50% and return on invested capital (ROIC) is -35.80%.
| Return on Equity (ROE) | -40.50% |
| Return on Assets (ROA) | -16.60% |
| Return on Capital (ROIC) | -35.80% |
| Revenue Per Employee | $218,921 |
| Profits Per Employee | -$142,548 |
| Employee Count | 228 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 3.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.55% in the last 52 weeks. The beta is 1.50, so OCUL's price volatility has been higher than the market average.
| Beta (1Y) | 1.50 |
| 52-Week Price Change | -47.55% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 4.45 |
| Average Volume (30 Days) | 617,543 |
Short Selling Information
The latest short interest is 3.44 million, so 4.48% of the outstanding shares have been sold short.
| Short Interest | 3.44M |
| Short % of Shares Out | 4.48% |
| Short % of Float | 4.88% |
| Short Ratio (days to cover) | 6.96 |
Income Statement
In the last 12 months, OCUL had revenue of $49.91 million and -32.50 million in losses. Earnings per share was -$1.02.
| Revenue | 49.91M |
| Gross Profit | 45.04M |
| Operating Income | -75.33M |
| Net Income | -32.50M |
| EBITDA | -23.51M |
| EBIT | -25.78M |
| Earnings Per Share (EPS) | -$1.02 |
Balance Sheet
The company has $136.30 million in cash and $59.47 million in debt, giving a net cash position of $76.84 million or $1.00 per share.
| Cash & Cash Equivalents | 136.30M |
| Total Debt | 59.47M |
| Net Cash | 76.84M |
| Net Cash Per Share | $1.00 |
| Book Value | 65.80M |
| Book Value Per Share | 0.86 |
| Working Capital | 134.21M |
Cash Flow
In the last 12 months, operating cash flow was -$57.61 million and capital expenditures -$1.68 million, giving a free cash flow of -$59.29 million.
| Operating Cash Flow | -57.61M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | -59.29M |
| FCF Per Share | n/a |
Margins
Gross margin is 90.24%, with operating and profit margins of -150.91% and -65.11%.
| Gross Margin | 90.24% |
| Operating Margin | -150.91% |
| Pretax Margin | n/a |
| Profit Margin | -65.11% |
| EBITDA Margin | -47.10% |
| EBIT Margin | -51.66% |
| FCF Margin | -118.78% |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -7.29% |
| FCF Yield | -13.29% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
Analyst Forecast
The average price target for OCUL is $15.13, which is 160.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.13 |
| Price Target Difference | 160.41% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |